AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 19 filers reported holding AN2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,783 | -87.5% | 2,785 | -93.4% | 0.00% | – |
| Q2 2023 | $359,058 | -20.1% | 42,242 | -7.2% | 0.00% | – |
| Q1 2023 | $449,401 | +14.2% | 45,532 | +10.2% | 0.00% | – |
| Q4 2022 | $393,637 | -43.7% | 41,305 | +2.7% | 0.00% | – |
| Q3 2022 | $699,000 | +123.3% | 40,233 | -0.2% | 0.00% | – |
| Q2 2022 | $313,000 | +2135.7% | 40,331 | +4457.2% | 0.00% | – |
| Q1 2022 | $14,000 | – | 885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 433,330 | $6,530,000 | 1.89% |
| RA Capital Management | 3,666,663 | $55,257,000 | 1.21% |
| BVF INC/IL | 1,616,665 | $24,363,000 | 0.98% |
| Avidity Partners Management LP | 688,330 | $10,373,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 584,136 | $8,803,000 | 0.20% |
| COWEN AND COMPANY, LLC | 60,278 | $908,000 | 0.09% |
| Woodline Partners LP | 150,000 | $2,261,000 | 0.04% |
| Alyeska Investment Group, L.P. | 125,000 | $1,884,000 | 0.02% |
| Citadel Advisors | 1,419,851 | $20,593,000 | 0.00% |
| Anson Funds Management LP | 2,500 | $38,000 | 0.00% |